Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Arterial Infusion Chemotherapy”

204 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 204 results

Not applicableLooking for participantsNCT05718492
What this trial is testing

The Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Study completedNCT05532319
What this trial is testing

HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC

Who this might be right for
Liver Cancer
Guangxi Medical University 64
Testing effectiveness (Phase 2)UnknownNCT04191889
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification

Who this might be right for
C-staged Hepatocellular Carcinoma in BCLC Classification
Sun Yat-sen University 47
Large-scale testing (Phase 3)Study completedNCT02856126
What this trial is testing

HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 214
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684040
What this trial is testing

Combination Therapy in Patients With Resectable Liver Cancer

Who this might be right for
Liver Cancer (Primary and Metastatic)
Affiliated Hospital of Guangdong Medical University 68
Testing effectiveness (Phase 2)Study completedNCT05003700
What this trial is testing

Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 39
Not applicableLooking for participantsNCT06641713
What this trial is testing

HAIC Compared With TACE in Huge Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatic ChemotherapyLiver Cancer
Sun Yat-sen University 664
Large-scale testing (Phase 3)UnknownNCT03780049
What this trial is testing

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 304
Not applicableStudy completedNCT06435013
What this trial is testing

Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC

Who this might be right for
Hepatocellular CarcinomaLenvatinib
Sun Yat-sen University 208
Not applicableEnded earlyNCT04276090
What this trial is testing

Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma

Who this might be right for
Bile Duct NeoplasmsColorectal Neoplasms
Michael J Cavnar, MD 21
Testing effectiveness (Phase 2)Looking for participantsNCT06741020
What this trial is testing

Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhejiang Cancer Hospital 10
Testing effectiveness (Phase 2)UnknownNCT04961918
What this trial is testing

The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 36
Not applicableUnknownNCT05002452
What this trial is testing

Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 150
Not applicableActive Not RecruitingNCT07466225
What this trial is testing

HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion

Who this might be right for
Hepatocellular Carcinoma (HCC)
Peking University 150
Testing effectiveness (Phase 2)Study completedNCT03366155
What this trial is testing

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerLiver MetastasesColorectal Adenocarcinoma+2 more
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)UnknownNCT04667351
What this trial is testing

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 400
Testing effectiveness (Phase 2)Looking for participantsNCT06397235
What this trial is testing

DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 130
Not applicableLooking for participantsNCT07466238
What this trial is testing

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
Peking University 40
Testing effectiveness (Phase 2)UnknownNCT00852228
What this trial is testing

Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy

Who this might be right for
Metastatic Colorectal CancerLiver MetastasesHepatic Lesions
Association pour la Recherche sur le Temps Biologique et la Chronothérapie 60
Not applicableStudy completedNCT06199297
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 188
Next Page